The Reciprocal Relationship Between Pharma & Homecare Medicine Services The relationship between pharmaceutical companies and homecare medicine services is symbiotic in nature. It is unlikely therefore, regardless of the VPAS…
The debate, on Wednesday 3rd May, focused on the need for the VPAS scheme to encourage life sciences investment in the UK. Anne-Marie Morris MP and Daniel Zeichner were both…
Summary highlights from our annual client survey With a focus on paying attention to our clients’ needs we have completed our fourth annual client survey and are excited to present…
Wishing all our clients, colleagues and their families a very Merry Christmas and a Happy New Year. We look forward to 2023, in the meantime we wish you all an…
November 2022 As CSL’s Omnichannel Benchmarking service continues to grow, how does your HCP engagement strategy compare to your competitors? Shown below is a snapshot of key insights from Q3…
EMIG Conducts a Member's Investment Intentions Survey November 2022The Ethical Medicines Interest Group (EMIG) recently surveyed members on 2023-member investment intentions related to the VPAS Rebate Level.Read on to see…
Get value out of your remaining end of year spend CSL offers a number of options for where to invest it; from getting datasets or Omnichannel comparison data through to…
By Matt Beckett, Managing Director and Lee Ronan, Commercial Director, CSL CSL’s managing director, Matt Beckett and Commercial Director, Lee Ronan, share their thoughts with Pharmaphorum on a new era…
CSL is proud to be Silver Sponsors of the NEXT Pharma Summit in Dubrovnik on 17 – 18 May 2022. With an agenda focusing on Commercial, Technology, Out of the…
Our short video below summarises the results of our 2021 client survey, highlighting why our clients work with us. Further survey results details can be found here. If you would like…
